7月22日，菲利普莫里斯盘中上涨4.02%，报196.61美元/股，成交额8541.25万美元。
消息面上，公司盘前发布Q2财报，当季营收增长10.4%至111.9亿美元，显著超出分析师预期的106.3亿美元。同时，美国FDA于7月初为旗下20款ZYN尼古丁袋产品发布改良风险烟草产品授权令，允许公司宣称使用ZYN替代香烟可降低多项重大疾病风险，构成重要催化剂。
值得注意的是，公司将全年调整后每股收益指引下调至8.11-8.26美元，低于市场预期的8.36美元，为年内第三次下调，主要受竞争加剧及汇率不利影响。此外，公司正加速投资Zyn业务，6月已推出Zyn Ultra系列并计划Q3新增多款规格产品，以巩固在尼古丁袋高增长细分市场的竞争力。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.